JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FRAZER, A.
Right arrow Articles by SHANFELD, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FRAZER, A.
Right arrow Articles by SHANFELD, J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 170, Issue 1, 10-16, 1969
Copyright © 1969 by American Society for Pharmacology and Experimental Therapeutics


THE EFFECTS OF THYROXINE ON RAT HEART ADENOSINE 3', 5'-MONOPHOSPHATE, PHOSPHORYLASE b KINASE AND PHOSPHORYLASE a ACTIVITY

ALAN FRAZER 1, MARILYN E. HESS 1, and JOSEPH SHANFELD 1

1 Department of Pharmacology, School of Mediaine, University of Pennsylvania, Philadelphia, Pennsylvania

The effects of chronic treatment with thyroxine or acute injection of epinephrine on cardiac adenosine 3', 5'-monophosphate (cyclic AMP), phosphorylase b kinase and phosphorylase a activity were studied in rats. In agreement with other investigators, we found that epinephrine caused an increase in cyclic AMP, activation of phosphorylase b kinase and increased activity of phosphorylase a. These metabolic effects of the catecholamine were blocked by the beta adrenergic blocking drug, MJ-1999. Although thyroxine increased myocardial phosphorylase a activity, there was neither an increase in cardiac cyclic AMP nor activation of phosphorylase b kinase. Heart homogenates from hyperthyroid rats showed enhanced phosphorylase b kinase activity which was not the result of conversion of the inactive molecular form to the active form of the enzyme. It was concluded that cardiac phosphorylase a activity is elevated by thyroxine through a mechanism different from that of epinephrine.

Submitted on May 8, 1969
Accepted on August 1, 1969







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics.